However, genetic alterations of both OCTN2 and OCTN1 coding genes are associated with the onset of inflammatory bowel diseases (IBDs), such as Crohn’s disease [92], which are becoming more and more interesting in terms of development of possible treatments, since chronic inflammation may play a role in the pathogenesis of sporadic colorectal cancer. This evidence concerns the gene SLC22A4 and inflammatory bowel disease.